Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.
Transcera's investors include Pear VC, Digitalis Ventures, Tau Ventures, KdT Ventures, MassChallenge.
Transcera is headquartered in Jamaica Plain, United States.
Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.
Transcera is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Transcera — Funding & Investors." VCBacked, July 27, 2023, https://www.vcbacked.co/company/transcera. Accessed July 20, 2026.
VCBacked. (2023). Transcera — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/transcera
{{cite web |title=Transcera — Funding & Investors |url=https://www.vcbacked.co/company/transcera |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated